Many pathogenic bacteria can use heme compounds as a source of iron. Pathogenic Escherichia coli strains are capable of using hemoglobin as an iron source. However, the mechanism of heme acquisition from hemoglobin is not understood for this microorganism. We present the first molecular characterization of a hemoglobin protease (Hbp) from a human pathogenic E. coli strain. The enzyme also appeared to be a heme-binding protein. Affinity purification of this bifunctional protein enabled us to identify the extracellular gene product, and to clone and analyze its gene. A purification procedure developed for Hbp allowed us to perform functional studies. The protein interacted with hemoglobin, degraded it and subsequently bound the released heme. These results suggest that the protein is involved in heme acquisition by this human pathogen. Hbp belongs to the so-called IgA1 protease-like proteins, as indicated by the kinetics of its membrane transfer and DNA sequence similarity. The gene of this protein appears to be located on the large pColV-K30 episome, that only has been isolated from human and animal pathogens. All these characteristics indicate that Hbp may be an important virulence factor that may play a significant role in the pathogenesis of E. coli infections.
Skip Nav Destination
Article navigation
21 September 1998
Article|
September 21 1998
Characterization of a Hemoglobin Protease Secreted by the Pathogenic Escherichia coli Strain EB1
Ben R. Otto,
Ben R. Otto
From the *Department of Molecular Microbiology, Institute of Molecular Biological Sciences, Biocentrum Amsterdam, 1081 HV Amsterdam, The Netherlands; and ‡Pharming BV, 2333 CA Leiden, The Netherlands
Search for other works by this author on:
Silvy J.M. van Dooren,
Silvy J.M. van Dooren
From the *Department of Molecular Microbiology, Institute of Molecular Biological Sciences, Biocentrum Amsterdam, 1081 HV Amsterdam, The Netherlands; and ‡Pharming BV, 2333 CA Leiden, The Netherlands
Search for other works by this author on:
Jan H. Nuijens,
Jan H. Nuijens
From the *Department of Molecular Microbiology, Institute of Molecular Biological Sciences, Biocentrum Amsterdam, 1081 HV Amsterdam, The Netherlands; and ‡Pharming BV, 2333 CA Leiden, The Netherlands
Search for other works by this author on:
Joen Luirink,
Joen Luirink
From the *Department of Molecular Microbiology, Institute of Molecular Biological Sciences, Biocentrum Amsterdam, 1081 HV Amsterdam, The Netherlands; and ‡Pharming BV, 2333 CA Leiden, The Netherlands
Search for other works by this author on:
Bauke Oudega
Bauke Oudega
From the *Department of Molecular Microbiology, Institute of Molecular Biological Sciences, Biocentrum Amsterdam, 1081 HV Amsterdam, The Netherlands; and ‡Pharming BV, 2333 CA Leiden, The Netherlands
Search for other works by this author on:
Ben R. Otto
From the *Department of Molecular Microbiology, Institute of Molecular Biological Sciences, Biocentrum Amsterdam, 1081 HV Amsterdam, The Netherlands; and ‡Pharming BV, 2333 CA Leiden, The Netherlands
Silvy J.M. van Dooren
From the *Department of Molecular Microbiology, Institute of Molecular Biological Sciences, Biocentrum Amsterdam, 1081 HV Amsterdam, The Netherlands; and ‡Pharming BV, 2333 CA Leiden, The Netherlands
Jan H. Nuijens
From the *Department of Molecular Microbiology, Institute of Molecular Biological Sciences, Biocentrum Amsterdam, 1081 HV Amsterdam, The Netherlands; and ‡Pharming BV, 2333 CA Leiden, The Netherlands
Joen Luirink
From the *Department of Molecular Microbiology, Institute of Molecular Biological Sciences, Biocentrum Amsterdam, 1081 HV Amsterdam, The Netherlands; and ‡Pharming BV, 2333 CA Leiden, The Netherlands
Bauke Oudega
From the *Department of Molecular Microbiology, Institute of Molecular Biological Sciences, Biocentrum Amsterdam, 1081 HV Amsterdam, The Netherlands; and ‡Pharming BV, 2333 CA Leiden, The Netherlands
Address correspondence to Ben R. Otto, Department of Molecular Microbiology, Institute of Molecular Biological Sciences, Biocentrum Amsterdam, De Boelelaan 1087, 1081 HV Amsterdam, The Netherlands. Phone: 31-20-4447176; Fax: 31-20-4447136; E-mail: [email protected]
Received:
April 22 1998
Revision Received:
June 16 1998
Online ISSN: 1540-9538
Print ISSN: 0022-1007
1998
J Exp Med (1998) 188 (6): 1091–1103.
Article history
Received:
April 22 1998
Revision Received:
June 16 1998
Citation
Ben R. Otto, Silvy J.M. van Dooren, Jan H. Nuijens, Joen Luirink, Bauke Oudega; Characterization of a Hemoglobin Protease Secreted by the Pathogenic Escherichia coli Strain EB1 . J Exp Med 21 September 1998; 188 (6): 1091–1103. doi: https://doi.org/10.1084/jem.188.6.1091
Download citation file:
Sign in
Don't already have an account? Register
Client Account
You could not be signed in. Please check your email address / username and password and try again.
Could not validate captcha. Please try again.
Sign in via your Institution
Sign in via your InstitutionSuggested Content
Email alerts
Advertisement